The National Drug Strategy 2010-2015: consultation draft
The aim of the National Drug Strategy 2010-2015 is to build safe and healthy communities by minimising alcohol, tobacco, illegal and other drug related health, social and economic harms among individuals, families and communities.
The harms to individuals, families, communities and Australian society as a whole from alcohol, tobacco, illegal and other drugs are well known. For example, the cost to Australian society of alcohol, tobacco, illegal and other drug misuse in the financial year 2004-05 was estimated at $56.1 billion, including costs to the health and hospitals system, lost workplace productivity, road accidents and crime.
The overarching approach of harm minimisation, which has guided the National Drug Strategy since its inception in 1985, will continue through 2010-2015. This encompasses the three pillars of:
- supply reduction to prevent, stop, disrupt or otherwise reduce the production and supply of illegal drugs; and control, manage and/or regulate the availability of legal drugs.
- demand reduction to prevent the uptake and/or delay the onset of use of alcohol, tobacco, illegal and other drugs; reduce the misuse of alcohol, tobacco, illegal and other drugs in the community; and support people to recover from dependence and reintegrate with the community.
- harm reduction to reduce the adverse health, social and economic consequences of the misuse of drugs.
In the National Drug Strategy 2010-2015, the three pillars are underpinned by strong commitments to:
- building workforce capacity
- evidence-based and evidence-informed practice, innovation and evaluation
- performance measuring and
- building partnerships across sectors.
Part 2 details specific objectives and suggested actions under each pillar.
Part 3 discusses the supporting approaches of workforce, evidence, performance monitoring and governance.